Tebarat® 0.5ml/ml - Allergic conjunctivities - single-dose vials eye drops - Rx

Cetraflux 3 mg/ml eye drop solution is indicated for the local treatment of the following infections caused by strains sensitive to ciprofloxacin, in adults, neonates (0-27 days), infants (aged 28 days to 23 months), children (aged 2-11 years), adolescents (aged 12-16 years). Available in single dose conta...

Monolitum Flas 15mg / 30mg - ODT formulation - Pack of 14, 28, 56 orally disintegrating tablets

Monolitum Flas 30mg - Acute treatment of duodenal ulcer, gastric ulcer and oesophagitis due to gastro-oesophageal reflux. Eradication of Helicobacter pylori in patients with duodenal ulcer and benig...

"The most complete range for each type of cystitis"

Urosens: MAINTENANCE in occasional urinary infections.
Urosens forte: ADJUVANT in urinary infectionsUrosens mannose: MAINTENANCE & ADJUVANT in urinary infections, very recurrent urinary infection

A sufficient dietary intake of the nutrients contained in Nurane Retina, supplemented when necessary, aids the correct functioning of the retina. Lutein and zeaxanthin are two carotenoids with antioxidant properties which help protect our bodies from attack by free radicals. They have the following functio...

Enables better digestion of dairy products. It helps break down lactose into its two constitutive elements (galactose and glucose) and prevents intestinal symptoms related to lactose intolerance (pain, abdominal swelling, meteorism and diarrhoea) from appearing after the consumption of any dairy product, p...

Dihydroartemisinin. Piperaquine Phosphate. Malaria

SVT-15473 is the first strongest ophthalmic corticosteroid formulated in nanoemulsion (nanodroplets below ~30nm), using IMPACT-SVT®, a patented drug delivery technology, and in single-dose vials, using Blow-Fill-Seal technology packaging.

SVT-15473 has&nbs...

Clotic® is a broad-spectrum otic antimycotic agent effective against pathogenic dermatophytes, yeasts and several species of fungus, Well-recognized safety and efficacy.
The first and only treatment with clinical evidence against otomycosis. Preservative-free.

Indication: Otic fu...

Salvat offers the best services and solutions, drawing on a long history of expertise in developing and manufacturing successful medications.

Tailored solutions to customer needs through our Ophthalmic platform: • • Customized solutions using Salvat's technology: suspensions, solutions, micellar,...

With 70 years of experience in developing and manufacturing pharmaceutical products for diverse markets, we excel in Operational Excellence, Flexibility, and Adaptability.

Salvat offers integrated CDMO services with state-of-the-art manufacturing facilities in Barcelona, Madrid, and Miami, equip...

Salvat specializes in developing and manufacturing sterile liquid pharmaceutical products in single-dose vials using Blow-Fill-Seal (BFS) technology.

Advantages of using Blow-Fill-Seal technology in your products: 
• • Innovative format, providing differentiation for your produ...

Bimeox® Bimatoprost 0.3 mg/ml, a well-known prostaglandin analogue eye drop, preservative-free, presented in single-dose vials using our Blow-Fill-Seal Technology.

• Innovative format in single-dose vials • Preservative-free for better tolerability • Sterile until ope...

• Los ensayos clínicos fase III realizados en adultos confirman la eficacia y el excelente perfil de seguridad de SVT-15473 clobetasol oftálmico, formulado con IMPACT-SVT® tecnología patentada de nanoemulsiones, para el tratamiento de la inflamación y el dolor después de una cirugía ocular.
• Es el primer estudio clínico que se realiza en paciente pediátrico con un corticoide tópico oftálmico en toda Europa.
• Con el nuevo estudio que se inicia ahora y que se llevará a cabo en seis hospitales españoles se espera demostrar también su seguridad en pacientes pediátricos de 0 a 3 años.
• Con este proyecto, que ha supuesto una inversión global de más de 20 millones de euros, Laboratorios Salvat da un paso más en su estrategia de afianzarse como un actor clave en el área de oftalmología a nivel internacional.

Salvat has developed IMPACT-SVT®, a patented nanoemulsion drug delivery technology that improves drug mucus penetration and bio-adhesion, providing excellent ocular comfort.

IMPACT-SVT® made it possible to develop SVT-15473, using the strongest corticosteroid in the global market.